☆ 4.0 Article

American College of Rheumatology Clinical Trial Priorities and Design Conference, July 22-23, 2010

ARTHRITIS AND RHEUMATISM (2011)

Get Full Text
Add to Collection

Journal

ARTHRITIS AND RHEUMATISM
Volume 63, Issue 8, Pages 2151-2156

Publisher

WILEY-BLACKWELL
DOI: 10.1002/art.30402

Keywords

-

Categories

Rheumatology

Funding

  1. Abbott
  2. Amgen
  3. Astellas
  4. Astra-Zeneca
  5. Biogen Idec
  6. Bristol-Myers Squibb
  7. Centocor
  8. Crescendo
  9. Lilly
  10. Pfizer
  11. Roche

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.